Prediction of pathological complete response and prognosis in patients with neoadjuvant treatment for triple-negative breast cancer

BACKGROUND: It has been reported that pathological complete response is an important surrogate marker for disease-free survival and overall survival in patients with triple-negative breast cancer. This study investigates predictors of the response to neoadjuvant platinum-based or anthracycline-based...

Descripción completa

Detalles Bibliográficos
Autores principales: Gass, Paul, Lux, Michael P., Rauh, Claudia, Hein, Alexander, Bani, Mayada R., Fiessler, Cornelia, Hartmann, Arndt, Häberle, Lothar, Pretscher, Jutta, Erber, Ramona, Wachter, David L., Schulz-Wendtland, Rüdiger, Beckmann, Matthias W., Fasching, Peter A., Wunderle, Marius
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6206705/
https://www.ncbi.nlm.nih.gov/pubmed/30373556
http://dx.doi.org/10.1186/s12885-018-4925-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6206705/
https://www.ncbi.nlm.nih.gov/pubmed/30373556
http://dx.doi.org/10.1186/s12885-018-4925-1

Ejemplares similares